Respiratory effects of opioid full and partial agonists in rhesus monkeys

被引:0
|
作者
Liguori, A [1 ]
Morse, WH [1 ]
Bergman, J [1 ]
机构
[1] HARVARD UNIV, NEW ENGLAND REG PRIMATE RES CTR, SCH MED, SOUTHBOROUGH, MA 01772 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Respiratory and behavioral effects of the mu selective opioids levorphanol (0.01-3.0 mg/kg), methadone (0.03-5.6 mg/kg) and codeine (0.3-30.0 mg/kg) and the mixed-action opioids buprenorphine (0.003-10.0 mg/kg), butorphanol (0.003-0.3 mg/kg) and nalbuphine (0.03-30.0 mg/kg) were studied in rhesus monkeys. In respiratory experiments, awake, seated monkeys wore plastic masks through which they breathed air or differing concentrations of CO2 mixed in air. Exposure to CO2 in air stimulated ventilation in a concentration-dependent manner. All opioids produced dose-dependent decreases in ventilation that were more pronounced as the concentration of CO2 increased. The highest doses of levorphanol, methadone, and butorphanol reduced the ventilatory stimulant effects of 5% CO2 in air by 85 to 90%, whereas the highest doses of nalbuphine, buprenorphine and codeine reduced the effects of 5% CO2 in air by only 50 to 75%. After presession butorphanol (0.01-0.1 mg/kg) or nalbuphine (1.0-3.0 mg/kg), levorphanol further reduced the ventilatory stimulant effects of 5% CO2 mixed in air, with some evidence of dose-effect flattening. However, pretreatment with buprenorphine (1.0-10.0 mg/kg) and the highest dose of nalbuphine (10.0 mg/kg) attenuated the effects of 10.0 mg/kg levorphanol, indicative of antagonism. In behavioral experiments, all drugs produced dose-related decreases in responding under a 30-response fixed-ratio schedule. The highest doses of levorphanol, methadone, codeine, and butorphanol nearly abolished responding in all subjects, whereas buprenorphine and nalbuphine most often reduced response rates by no more than 50%. Except for codeine, rank orders of potency were the same in behavioral and respiratory experiments. The lesser effects of nalbuphine and buprenorphine on venlilation, in conjunction with their levorphanol-anlagonist effects, suggest their limited mu agonist efficacy at sites mediating the respiratory-depressant effects of opioids.
引用
收藏
页码:462 / 472
页数:11
相关论文
共 50 条
  • [31] Effects of Opioid/cannabinoid Mixtures on Impulsivity and Memory in Rhesus Monkeys
    Minervini, Vanessa
    France, Charles P.
    FASEB JOURNAL, 2019, 33
  • [32] Some effects of putative G-protein biased mu-opioid receptor agonists in male rhesus monkeys
    Cornelissen, Jeremy C.
    Blough, Bruce E.
    Bohn, Laura M.
    Negus, S. Stevens
    Banks, Matthew L.
    BEHAVIOURAL PHARMACOLOGY, 2021, 32 (05): : 453 - 458
  • [33] Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine
    Negus S.S.
    Gatch M.B.
    Mello N.K.
    Neuropsychopharmacology, 1998, 18 (5) : 325 - 338
  • [34] Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine
    Negus, SS
    Gatch, MB
    Mello, NK
    NEUROPSYCHOPHARMACOLOGY, 1998, 18 (05) : 325 - 338
  • [35] Enadoline discrimination in squirrel monkeys: Effects of opioid agonists and antagonists
    Carey, GJ
    Bergman, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 215 - 223
  • [36] Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys
    Gerak, Lisa R.
    Maguire, David R.
    Woods, James H.
    Husbands, Stephen M.
    Disney, Alex
    France, Charles P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 368 (02): : 229 - 236
  • [37] Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception
    Jun-Xu Li
    Lance R. McMahon
    Lisa R. Gerak
    Ginger L. Becker
    Charles P. France
    Psychopharmacology, 2008, 199 : 199 - 208
  • [38] Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys:: discrimination and antinociception
    Li, Jun-Xu
    McMahon, Lance R.
    Gerak, Lisa R.
    Becker, Ginger L.
    France, Charles P.
    PSYCHOPHARMACOLOGY, 2008, 199 (02) : 199 - 208
  • [39] EFFECTS OF BUPRENORPHINE AND OTHER OPIOID AGONISTS AND ANTAGONISTS ON ALFENTANIL-REINFORCED AND COCAINE-REINFORCED RESPONDING IN RHESUS-MONKEYS
    WINGER, G
    SKJOLDAGER, P
    WOODS, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 261 (01): : 311 - 317
  • [40] EFFECTS OF OPIOID AGONISTS SELECTIVE FOR MU-OPIOID, KAPPA-OPIOID AND DELTA-OPIOID RECEPTORS ON SCHEDULE-CONTROLLED RESPONDING IN RHESUS-MONKEYS - ANTAGONISM BY QUADAZOCINE
    NEGUS, SS
    BURKE, TF
    MEDZIHRADSKY, F
    WOODS, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (02): : 896 - 903